Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,731 public trials 2,241 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Active, Not Recruiting

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

NCT05948826

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Cancer, +10 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Fort Wayne Medical Oncology and Hematology Inc. Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

NCT06257875

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Gastro SB /ID# 258331 Chula Vista, California, United States
  • Southern California Res. Ctr. /ID# 258391 Coronado, California, United States
  • Newport Huntington Medical Group /ID# 258371 Huntington Beach, California, United States
  • Om Research LLC /ID# 261383 Lancaster, California, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)

NCT06127043

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • AnaptysBio Investigational Site 10-115 Phoenix, Arizona, United States
  • AnaptysBio Investigational Site 10-117 Garden Grove, California, United States
  • AnaptysBio Investigational Site 10-112 Lancaster, California, United States
  • AnaptysBio Investigational Site 10-129 Lancaster, California, United States
View all 100 locations
View Trial Details
Active, Not Recruiting

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

NCT04008030

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Local Institution - 0059 Los Angeles, California, United States
  • Local Institution - 0130 Sacramento, California, United States
  • Local Institution - 0103 Denver, Colorado, United States
  • Local Institution - 0119 Arlington Heights, Illinois, United States
View all 157 locations
View Trial Details

Related conditions